Connecticut Children's Medical Center has been awarded a $10.5 million dollar grant from the National Institutes of Health for a five-year study of the effects of standardized therapy for children with ulcerative colitis.
The study, which is being led by Dr. Jeffrey Hyams, the director of the Connecticut Children's division of digestive diseases, hepatology and nutrition, has enlisted 25 leading pediatric institutions throughout the United States and Canada. Enrollment, which will focus on children between four and 17 years of age who are newly diagnosed with ulcerative colitis, is expected to begin this July. Participants will be followed for up to 5 years to monitor disease status.
The University of North Carolina Clinical Studies Coordinating Center will serve as the data coordinating center.
The grant is the first and largest multi-center pediatric clinical study that Connecticut Children's has received from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.